CBIO
Crescent Biopharma, Inc.
14.50$
+3.9%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +33.6% | -99.9% | – | – | – | – | -88.6% | -93.5% | -86.7% | – | – | |
| – | – | – | – | +4.4% | +226.9% | +5.8% | – | – | -85.1% | -77.1% | +138.8% | |
| – | +33.6% | -99.9% | -1,524.5% | – | – | – | -88.6% | -93.5% | -86.7% | -451.7% | – | |
| – | +28.0% | -7.1% | +3.5% | +66.4% | +17.3% | -4.5% | +5.7% | -40.2% | -29.3% | +39.8% | +392.1% | |
| – | +18.3% | +10.8% | +13.7% | +16.1% | +25.8% | +16.6% | +2.2% | +11.5% | +0.7% | -15.0% | +55.5% | |
| – | +25.6% | -2.8% | +5.4% | +53.0% | +19.2% | +0.5% | +4.8% | -26.5% | -17.3% | +27.0% | +227.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +156.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -216.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.